Targeting Breast Cancer Metastasis, and more

Cancer Stories From The Scientist

View in browser October 17, 2023 Advertisement   Targeting Breast Cancer Metastasis By Tanvir Khan, PhD Researchers targeted molecules that regulate both tumor and immune cell migration and their crosstalk signaling to impede metastasis.     Long-Read Sequencing Highlights Structural Variants in Cancer By Oxford Nanopore Technologies Conventional short-read sequencing often misses large and complex genome variants. In this article from Oxford Nanopore Technologies, learn how researchers used nanopore sequencing to investigate structural variants in colorectal tumors.   Advertisement   Interview: Mega Multiplexing for Exploring Diseased Tissues By Niki Spahich, PhD Researchers at KU Leuven specialize in performing a multiplex immunohistochemistry method that uses conventional antibodies and pathologist-driven data analysis.     Infographic: Dedicated Solutions for NGS Problem-Solving By Roche When experiencing trouble with complex next generation sequencing workflows, researchers can turn to an NGS support network for help. Learn more in this infographic from Roche.   The Scientist's Creative Services Team inbox is always open, so if you have questions or comments, we'd love to hear from you. Send Us Your Feedback »   Never miss an email from The Scientist. Click here to add The Scientist to your safe-sender list. The Scientist, 1000 N West Street, Suite 1200,  Wilmington, Delaware, United States, 19801   Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com www.the-scientist.com You received this email because you are subscribed to The Scientist Special Offers and Promotions from The Scientist. Click to Unsubscribe | View Privacy Policy Stop receiving email from The Scientist